GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Total Current Liabilities

Akanda (Akanda) Total Current Liabilities : $10.17 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Akanda Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Akanda's total current liabilities for the quarter that ended in Dec. 2023 was $10.17

Akanda Total Current Liabilities Historical Data

The historical data trend for Akanda's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akanda Total Current Liabilities Chart

Akanda Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Liabilities
- 2.73 8.27 9.35 10.17

Akanda Quarterly Data
Dec19 Sep20 Dec20 Jun21 Sep21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.27 6.27 9.35 12.38 10.17

Akanda Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Akanda's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=8.67+1.502
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=10.17

Akanda's Total Current Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=8.67+1.502
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=10.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Akanda Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Akanda's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Akanda (Akanda) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akanda Corp (NAS:AKAN) » Definitions » Total Current Liabilities
Comparable Companies
VFRM CPMD BSPK NXEN PCYN ENDPQ CSUI HCANF YCBD SXTC ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
Y230:Germany
Address
1A, 1B Learoyd Road, New Romney, GBR, TN28 8XU
Website
https://www.akandacorp.com
Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.

Akanda (Akanda) Headlines

From GuruFocus

Akanda Corp. Announces Termination of Loan Agreement

By Business Wire Business Wire • 05-29-2023

Akanda Targets 10% of German Medical Cannabis Market with its Premium Flower Cultivation Operations in Portugal

By Business Wire Business Wire • 11-16-2022

/R E P E A T -- Halo Collective Reports First Quarter 2022 Financial Results; Book Value Per Share of $1.65 ($2.12 CAD)/

By PRNewswire PRNewswire • 06-26-2022

Cansativa Group and Akanda Corp. to Bring New Medical Cannabis Flowers to Germany

By Business Wire Business Wire • 08-09-2022

Akanda Books �1.8M of Revenue in Q4 2022 As German Sales Start

By Business Wire Business Wire • 02-02-2023

Akanda's CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK

By Business Wire Business Wire • 06-29-2022

Akanda Corp. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

By Business Wire • 07-06-2023

Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access

By Business Wire Business Wire • 04-20-2022

Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA)

By Business Wire Business Wire • 05-02-2022

Akanda Corp. Common Shares Set to Commence Trading Today on Nasdaq Under Ticker Symbol "AKAN"

By Business Wire Business Wire • 03-15-2022